# Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations

> **NCT01392703** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 141 (actual)

## Conditions studied

- Pharmacokinetic Study in Healthy Participants

## Interventions

- **DRUG:** Dasatinib as tablets
- **DRUG:** Dasatinib as liquid
- **DRUG:** Dasatinib as dispersed tablets

## Key facts

- **NCT ID:** NCT01392703
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01392703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01392703, "Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01392703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*